Ivantist Treats Glaucoma
Ivantis Microstent Technology
Ivantis MicroStent News & Events

The Hydrus Microstent Ivantis HYDRUS IV United States Clinical Trial

Contact Ivantis Microstent Developers
 

Ivantis News/Press Releases

Ivantis Raises $25 Million Series C to Fund Future US Commercialization of the Hydrus™ Microstent for Minimally Invasive Glaucoma Surgery (MIGS) (January, 2017)

Ivantis Completes Enrollment in Pivotal HYDRUS IV Glaucoma Study of the Hydrus™ Microstent (April, 2015)

Ivantis Announces HYDRUS II Glaucoma Study Met Primary Endpoint In a Randomized Controlled Trial at Two Years (October, 2014)

Ivantis Raises Additional $25 MM, Increasing Series B to $71 MM (September, 2014)

Ivantis Completes a $46.5 MM Financing; Company Receives Approval to Expand US Pivotal Trial for Novel Glaucoma Device (January, 2014)

Ivantis Raises Additional $5 MM from Singapore-based Global Investor, EDBI, Increasing Series B to $32.5 MM (August, 2013)

Micro-stents progressively defining their role in glaucoma management (July, 2013)

Combined Cataract Surgery and MIGS: Which Procedures Will Be a Match Made in Heaven? (April, 2013)

Ivantis Announces Completion of $27 MM Financing for Novel Glaucoma Procedure. (January, 2013)

Ivantis Enrolls First US Patient for Clinical Studies on Glaucoma (March, 2012)

Ivantis Announces Results of Hydrus™ Intracanalicular Implant Study
(September, 2011)

Ivantis Announces Completion of $17 MM Financing, CE Mark Approval, and Initiation of International Randomized Controlled Trial for Revolutionary Glaucoma Procedure (June, 2011)

Scientific Abstracts and Posters

A Novel Schlemm’s Canal Scaffold Increases Outflow Facility in a Human Anterior Segment Perfusion Model

A Novel Schlemm’s Canal Scaffold: Histologic Observations

A Novel 8-mm Schlemm’s Canal Scaffold Reduces Outflow Resistance in a Human Anterior Segment Perfusion Model

Effects of a Schlemm canal scaffold on collector channel ostia in human anterior segments

One-year Results of a Schlemm's Canal Microstent for IOP Reduction in Open Angle Glaucoma (AAO - APAO, 2012)

6 Month Results from a Prospective, Multicenter Study of a Nickel-titanium Schlemm’s Canal Scaffold for IOP Reduction in Open Angle Glaucoma
(American Glaucoma Society, 2012)

Characterization of Aqueous Outflow Through a Novel Schlemm’s Canal Scaffold - A Tracer Study (American Glaucoma Society, 2012)

6 Month Results from a Prospective, Multicenter Study Of a Nickel-titanium Schlemm’s Canal Scaffold for IOP Reduction After Cataract Surgery in Open Angle Glaucoma (American Glaucoma Society, 2012)

A Novel Schlemm’s Canal Scaffold Maintains Patency of Collector Channel Ostia in Human Anterior Segments (American Glaucoma Society, 2012)

Intracanalicular Scaffold for IOP Reduction with Cataract Surgery in Mild to Moderate open Angle Glaucoma (Won "Best of Session" Award at ASCRS)